RP Management, LLC 13F Holdings · last filed Q1 2025
RP Management, LLC reported 4 securities worth $138.84M in its SEC 13F filing for Q1 2025 (period ended 2025-03-31). Top holdings: BHVN (50.84%), CYTK (28.38%), BCRX (20.78%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BHVN | BIOHAVEN LTD | $70.6M | 50.84% | 2.9M | Hold |
| 2 | CYTK | CYTOKINETICS, INC | $39.4M | 28.38% | 980,392 | Hold |
| 3 | BCRX | BIOCRYST PHARMACEUTICALS INC | $28.8M | 20.78% | 3.8M | Hold |
| 4 | VIRX | VIRACTA THERAPEUTICS INC | $74 | 0.00% | 3,700 | Hold |
Source: SEC Form 13F filings · as of 2025-03-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR